Johns Hopkins Medicine Researchers Create Machine Learning Model To Calculate Chemotherapy Success In Patients With Osteosarcoma

A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN) — or, what percentage of a tumor is “dead” and no longer active — in patients with osteosarcoma, a type of bone cancer. The model’s calculation was 85% correct when compared to the results of a musculoskeletal pathologist.

Childhood Cancer Awareness Month Has Special Meaning for Johns Hopkins Children’s Center Pediatric Oncology Nurse

For the past three years, nurse Lauren Chelenza has cared for hundreds of children with cancer while working on the pediatric oncology inpatient unit at Johns Hopkins Children’s Center in Baltimore. It’s a place she never imagined she’d be working 15 years ago, while going through her own cancer treatment.

MD Anderson Research Highlights: AACR 2023 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Malignant Cancer Diagnosed in a Dinosaur for the First Time

A collaboration led by the Royal Ontario Museum (ROM) and McMaster University has led to the discovery and diagnosis of an aggressive malignant bone cancer — an osteosarcoma — for the first time ever in a dinosaur. No malignant cancers (tumours that can spread throughout the body and have severe health implications) have ever been documented in dinosaurs previously. The paper was published August 3rd in the prestigious medical journal The Lancet Oncology.